Published in Am J Pathol on January 01, 1991
Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest (1992) 4.49
Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med (2006) 2.00
High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest (1998) 1.71
Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest (1995) 1.21
Cyclic stretching force selectively up-regulates transforming growth factor-beta isoforms in cultured rat mesangial cells. Am J Pathol (1996) 1.17
Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J Pathol (1994) 1.11
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol (1996) 1.00
Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. Am J Pathol (2010) 0.99
Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines. Am J Pathol (2000) 0.95
Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol (1992) 0.93
Biological approaches to improve skeletal muscle healing after injury and disease. Birth Defects Res C Embryo Today (2012) 0.91
Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells. Am J Pathol (1992) 0.90
Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis. Am J Pathol (1993) 0.88
Role of smooth muscle protein SM22α in glomerular epithelial cell injury. Am J Physiol Renal Physiol (2011) 0.87
Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis. Am J Pathol (1995) 0.85
Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium. J Clin Invest (1995) 0.83
Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease. Am J Pathol (1996) 0.81
Intraglomerular expression of transforming growth factor-beta 1 (TGF-beta 1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction. Clin Exp Immunol (1994) 0.79
Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota. Biochem J (2003) 0.79
Long-term evolution of the acute tubular necrosis (ATN) induced by glycerol: role of myofibroblasts and macrophages. Int J Exp Pathol (2002) 0.78
Interaction of baboon anti-alpha-galactosyl antibody with pig tissues. Am J Pathol (1999) 0.77
Analysis of T cells and major histocompatibility complex class I and class II mRNA and protein content and distribution in antiglomerular basement membrane disease in the rabbit. Am J Pathol (1991) 0.77
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell (1980) 17.55
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature (1985) 10.13
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry (1971) 7.39
Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell (1983) 6.27
Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol (1987) 5.25
Transforming growth factor-beta: biological function and chemical structure. Science (1986) 5.08
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (1990) 4.64
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med (1987) 4.35
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol (1988) 4.34
Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J Biol Chem (1988) 3.98
Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. J Cell Physiol (1989) 3.58
Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry (1983) 3.49
Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med (1989) 2.99
Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem Biophys Res Commun (1985) 2.75
The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem (1987) 2.64
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
The structure of rat 28S ribosomal ribonucleic acid inferred from the sequence of nucleotides in a gene. Nucleic Acids Res (1983) 2.43
Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem (1987) 2.17
Glomerular cell culture. Lab Invest (1985) 2.16
Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. J Biol Chem (1987) 2.15
Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem (1987) 2.05
Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int (1990) 2.04
Stimulation of rat mesangial cell proliferation by macrophage interleukin 1. J Immunol (1983) 1.94
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci U S A (1987) 1.64
Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int (1987) 1.60
Amino acid sequence of the non-collagenous globular domain (NC1) of the alpha 1(IV) chain of basement membrane collagen as derived from complementary DNA. Eur J Biochem (1985) 1.48
Tissue culture of normal rat glomeruli. Isolation and morphological characterization of two homogeneous cell lines. Invest Cell Pathol (1980) 1.27
The origin of glomerular crescents in experimental nephrotoxic serum nephritis in the rabbit. Lab Invest (1978) 1.24
Bi-functional action of transforming growth factor-beta on DNA synthesis in early passage human fetal fibroblasts. J Cell Physiol (1986) 1.21
Analysis of renal fibrosis in a rabbit model of crescentic nephritis. J Clin Invest (1988) 1.20
Mesangial cells, effect of monocyte products on proliferation and matrix synthesis. Transplant Proc (1982) 1.15
Regulation of mesangial cell growth by polypeptide mitogens. Inhibitory role of transforming growth factor beta. Am J Pathol (1989) 1.14
Mechanisms of suppression of mouse mesangial cell proliferation by macrophage supernatants. J Immunol (1983) 1.11
Procoagulant activity in glomeruli and urine of rabbits with nephrotoxic nephritis. Lab Invest (1985) 1.10
One of two subunits of masking protein in latent TGF-beta is a part of pro-TGF-beta. FEBS Lett (1989) 0.99
Origin of glomerular crescents in rabbit nephrotoxic nephritis. J Pathol (1983) 0.79
Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science (1989) 4.99
Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol (1994) 3.57
Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem (1984) 3.32
Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem (1989) 2.43
Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol (1986) 2.37
Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int (2001) 2.33
Estimating the prevalence of disability in the community: the influence of sample design and response bias. J Epidemiol Community Health (1981) 2.11
Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol (1999) 2.09
Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem (1991) 2.06
Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem (1996) 2.05
Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. Biochem Biophys Res Commun (1989) 2.01
Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol (2000) 1.97
Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol (1996) 1.92
Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol (1992) 1.88
Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis. Am J Pathol (1995) 1.80
ThinPrep Processor. Clinical trials demonstrate an increased detection rate of abnormal cervical cytologic specimens. Am J Clin Pathol (1994) 1.79
The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis (1983) 1.71
A role for C-C chemokines in fibrotic lung disease. J Leukoc Biol (1995) 1.60
A large outbreak of cryptosporidiosis associated with a public water supply from a deep chalk borehole. Outbreak Investigation Team. Commun Dis Public Health (1998) 1.59
Bleomycin-induced pulmonary fibrosis. Effects of steroid on lung collagen metabolism. Am Rev Respir Dis (1981) 1.48
The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. A biochemical evaluation. Am Rev Respir Dis (1983) 1.46
Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection. Transfusion (1994) 1.45
Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol (1994) 1.44
TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J Immunol (1997) 1.43
Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol (1991) 1.42
Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury. J Immunol (1994) 1.42
Rat lung fibroblast collagen metabolism in bleomycin-induced pulmonary fibrosis. J Clin Invest (1985) 1.40
Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. Int J Biochem Cell Biol (2001) 1.39
Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Curr Med Chem (2009) 1.39
Induction of telomerase activity in fibroblasts from bleomycin-injured lungs. Am J Respir Cell Mol Biol (2000) 1.39
Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des (2001) 1.32
TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury. J Leukoc Biol (1998) 1.24
Bleomycin-induced pulmonary fibrosis in rats: biochemical demonstration of increased rate of collagen synthesis. Am Rev Respir Dis (1980) 1.21
The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Am J Pathol (1981) 1.21
Analysis of renal fibrosis in a rabbit model of crescentic nephritis. J Clin Invest (1988) 1.20
Cytokines and pulmonary fibrosis. Biol Signals (1997) 1.20
Identification of structural and functional domains in mixed lineage kinase dual leucine zipper-bearing kinase required for complex formation and stress-activated protein kinase activation. J Biol Chem (2000) 1.19
Source of iron in neutrophil-mediated killing of endothelial cells. Lab Invest (1987) 1.17
Mucinase and sialidase activity of the vaginal microflora: implications for the pathogenesis of preterm labour. Int J STD AIDS (1999) 1.17
Cryptosporidium meleagridis from humans: molecular analysis and description of affected patients. J Infect (2001) 1.15
Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1beta. J Immunol (1997) 1.15
In situ hybridization analysis of rat lung alpha 1(I) and alpha 2(I) collagen gene expression in pulmonary fibrosis induced by endotracheal bleomycin injection. Lab Invest (1994) 1.12
Auto theft-related trauma. J Trauma (1998) 1.12
Social inequalities in health by individual and household measures of social position in a cohort of healthy people. J Epidemiol Community Health (2003) 1.11
Falls: epidemiology and strategies for prevention. J Trauma (1995) 1.10
Antiapoptotic effect of found in inflammatory zone (FIZZ)1 on mouse lung fibroblasts. J Pathol (2007) 1.10
An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis. J Pathol (2007) 1.09
Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. J Invest Dermatol (1993) 1.07
Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites. J Leukoc Biol (1987) 1.07
Measurement of intracellular fluorescence of human monocytes relative to oxidative metabolism. J Leukoc Biol (1988) 1.06
Antibody-induced receptor loss. Different fates for asialoglycoproteins and the asialoglycoprotein receptor in HepG2 cells. J Biol Chem (1986) 1.06
Doctor diagnosis and maternal recall of lower respiratory illness. Int J Epidemiol (1982) 1.05
H2O2-mediated cytotoxicity of rat pulmonary endothelial cells. Changes in adenosine triphosphate and purine products and effects of protective interventions. Lab Invest (1990) 1.04
All-trans retinoic acid stimulates growth and extracellular matrix production in growth-inhibited cultured human skin fibroblasts. J Invest Dermatol (1990) 1.03
Lung interleukin-5 expression in murine bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (1997) 1.01
Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokine (2001) 1.01
Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production. Am J Pathol (1986) 1.00
Secretion of monocyte chemotactic activity by alveolar macrophages. Am J Pathol (1989) 0.99
Inhibition of cytotoxicity by intracellular superoxide dismutase supplementation. Free Radic Biol Med (1990) 0.99
Cellular sensitivity to collagen in bleomycin-treated rats. J Immunol (1982) 0.98
The role of eosinophils in pulmonary fibrosis (Review). Int J Mol Med (1998) 0.98
Transforming growth factor-beta 1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells. J Vasc Surg (1997) 0.98
C-C chemokines: novel mediators of the profibrotic inflammatory response to bleomycin challenge. Am J Respir Cell Mol Biol (1996) 0.97
Lipid microvesicles and their association with procoagulant activity in urine and glomeruli of rabbits with nephrotoxic nephritis. Lab Invest (1987) 0.96
The role of IL-5 in bleomycin-induced pulmonary fibrosis. J Leukoc Biol (1998) 0.96
Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome. Exp Nephrol (1998) 0.95
The inhibiton of adrenergically provoked renin release by salbutamol in man. Br J Clin Pharmacol (1978) 0.95
Screening of the anticoccidial effects of herb extracts against Eimeria tenella. Vet Parasitol (2001) 0.95
Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1. Am J Physiol (1992) 0.94
Identification of Acanthocephala discovered in changran-pickles and myungran-pickles. J Vet Sci (2001) 0.93
Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5. Proc Natl Acad Sci U S A (1979) 0.92
Inhibition of bleomycin-induced pulmonary fibrosis by cobra venom factor. Am J Pathol (1982) 0.92
Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr Pharm Des (2005) 0.92
Platelet enhancement of O2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide. Lab Invest (1988) 0.92
Nephrology core curriculum. The American Society of Nephrology and the American Society of Nephrology Training Program Directors Committee. J Am Soc Nephrol (1997) 0.92
Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol Dial Transplant (2001) 0.91
Studies on cytochrome oxidase. Preliminary characterization of an enzyme containing only four subunits. J Biol Chem (1976) 0.91
Fibronectin mRNA and protein accumulation, distribution, and breakdown in rabbit anti-glomerular basement membrane disease. J Am Soc Nephrol (1991) 0.90
Studies on cytochrome oxidase. Partial resolution of enzymes containing seven or six subunits, from yeast and beef heart, respectively. J Biol Chem (1976) 0.90
Glomerular epithelial protein 1 and podocalyxin-like protein 1 in inflammatory glomerular disease (crescentic nephritis) in rabbit and man. Lab Invest (1996) 0.90
Low-energy impedance-compensating biphasic waveforms terminate ventricular fibrillation at high rates in victims of out-of-hospital cardiac arrest. LIFE Investigators. J Cardiovasc Electrophysiol (1997) 0.89
Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFbeta. Oncogene (2006) 0.89
Functional defects in phagocytic cells following thermal injury. Application of flow cytometric analysis. Am J Pathol (1985) 0.89
Inhibition by tosyl-L-phenylalanyl chloromethyl ketone of membrane potential changes in rat neutrophils. Correlation with the inhibition of biological activity. J Biol Chem (1983) 0.89
Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysaccharide. Lab Invest (1984) 0.88
Modulation of bleomycin-induced pulmonary fibrosis in the BALB/c mouse by cyclophosphamide-sensitive T cells. Am J Pathol (1984) 0.88
Effect of the beige mutation on bleomycin-induced pulmonary fibrosis in mice. Am Rev Respir Dis (1983) 0.87
Membrane protein alterations in the neutrophil in response to chemotactic factors. Mol Immunol (1980) 0.86
Molecular properties of cis,cis-muconate cycloisomerase from Pseudomonas putida. J Mol Biol (1974) 0.86
The role of soluble factors in bleomycin-induced pulmonary fibrosis. Am J Pathol (1982) 0.86
Glomerular basement membrane-containing immune complexes stimulate tumor necrosis factor and interleukin-1 production by human monocytes. Am J Pathol (1989) 0.86
Generation of biologic activity from the purified alpha-chain of C5. J Immunol (1979) 0.85
Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury. Am J Respir Cell Mol Biol (1993) 0.84
The relationship between plasma leptin and nutritional status in chronic hemodialysis patients. J Korean Med Sci (1999) 0.83
The effects of bleomycin on alveolar macrophage growth factor secretion. Am J Pathol (1989) 0.83
Inhibition of neutrophil activation by p-bromophenacyl bromide and its effects on phospholipase A2. Br J Pharmacol (1986) 0.83
A comparative study of pulmonary fibrosis induced by bleomycin and an O2 metabolite producing enzyme system. Chest (1983) 0.82